Tata Power Renewable gets Rs 2,000 cr infusion from GreenForest

Tata Power Renewable Energy Ltd (TPREL) has received a Rs 2,000 crore investment from GreenForest New Energies Bidco, with the latter receiving 20 crore preference shares. “TPREL has received the second and final round of investment of Rs 2,000 crore from GreenForest and has successfully allotted 20,00,00,000 Compulsorily Convertible Preference Shares (CCPS) at face value

Read More »

Infosys Collaborates with Motherhood Hospitals to Foster Learning in Healthcare through Infosys Springboard

This groundbreaking collaboration will democratise healthcare education for students, graduates, and lifelong learners. Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has signed an MoU with Motherhood Hospitals, a specialty hospital chain providing women and child-care, to digitally upskill learners in the healthcare sector through

Read More »

Zydus gets final approval from USFDA for Olmesartan Medoxomil and Hydrochlorothiazide Tablets

Zydus Lifesciences Limited (including its subsidiaries and affiliates, collectively referred to as “Zydus”) has received final FDA approval for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg, 40 mg/12.5 mg, and 40 mg/25 mg (USRLD: Benicar HCT ® Tablets). As the name implies, Olmesartan Medoxomil and Hydrochlorothiazide is a combination of two medications: Olmesartan and

Read More »

Zydus has received final FDA approval for Apixaban Tablets, 2.5 mg and 5 mg

The United States Food and Drug Administration (USFDA) has granted final approval to Zydus Lifesciences Limited (including its subsidiaries / affiliates, hereafter referred to as “Zydus”) for Apixaban Tablets, 2.5 mg and 5 mg (USRLD: Eliquis® Tablets). Apixaban inhibits the activity of certain clotting factors in the blood. It is used to reduce the risk

Read More »

Aditya Birla Capital Ltd collaborates with NPCI to develop and promote digital payments

Aditya Birla Capital announced a partnership with National Payments Corporation of India (NPCI) to develop and promote digital payment methods to its customers through subsidiaries. This collaboration marks Aditya Birla Capital’s entry into the payments space through its operating subsidiaries, with the goal of promoting digital payments through faster adoption of new technologies in collaboration

Read More »

Ahluwalia Contracts India Ltd has received a Rs. 169 crore order

Ahluwalia Contracts (India) Limited has received an order from Indian Financial Technologies and Allied Services (IFTAS) for the construction of civil and structural works for a data centre complex in Bhubaneswar, Orissa, worth approximately Rs. 169 crores. To date, the order inflow for the fiscal year 2022-23 stands at Rs.4333.63 crores. Ahluwalia Contracts (India) Limited

Read More »

Time Technoplast Ltd receives a new order worth Rs. 25 crores

Time Technoplast Ltd has received an additional order worth approximately INR 25 crores (approx.) from Maharashtra Natural Gas Limited (MNGL), a joint venture of GAIL (India) and BPCL. Previously, the company had received an order for INR 134 crores. With this, MNGL’s total order stands at INR 159 Crores (approx.) to be supplied within the

Read More »

Alembic Pharmaceuticals gets USFDA approval for Docetaxel Injection

Alembic Pharmaceuticals (Alembic) announced today that it has received final FDA approval for its Abbreviated New Drug Application (ANDA) Docetaxel Injection USP, 20 mg/2 mL (10 mg/mL) Single Dose Vial, as well as 80 mg/8 mL (10 mg/mL) and 160 mg/16 mL (10 mg/mL) Multiple-Dose Vials. The approved ANDA is therapeutically equivalent to the reference

Read More »
Shopping Cart
Scroll to Top